1. Home
  2. Corporate Information
  3. Company Overview

Corporate Information

Company Overview

(As of March 1, 2018)
Company Name RaQualia Pharma Inc.
Head Office 8F Daiwa Meieki Bldg., 1-21-19 Meieki Minami
Nakamura-ku, Nagoya, 450-0003
Discovery Research

Nagoya University
Furo-cho, Chikusa-ku, Nagoya, 464-8601

Research Institute of Environmental Medicine
Institute for Advanced Research Hall 2F

National Innovation Complex (NIC) 8F

Business Summary Discovery and development of pharmaceutical compounds
Licensing of intellectual properties for pharmaceutical compounds
Establishment February 19, 2008
Capital Fund 2.78 billion yen
Employees 60
Board of Directors
Representative Director
Naoki Tani
Hatsuo Aoki
Kiichiro Kawada
Shuzo Watanabe
Audit & Supervisory Committee Member
Shinnosuke Maki
Audit & Supervisory Committee Member
Hisaji Agata
Audit & Supervisory Committee Member
Gakuji Nomoto
Executive Vice President
Kiichiro Kawada
Senior Vice President
Shuzo Watanabe
Vice President
Yasuhiro Takamatsu


Company Name TMRC Co., Ltd.
Establishment January 25, 2002
URL http://www.tmrc.co.jp/

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Press Release
Research & Development
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release